))
The Standard of Care for Metastatic Prostate Cancer
Manage episode 429329039 series 3585940
Inhoud geleverd door JNM. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door JNM of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead researchers on this ground-breaking study as he discusses how the trial has opened up a completely new field of study in prostate cancer research and shaped the future of nuclear medicine therapy in combatting the disease. Join us for Episode 4 of JNM Podcast from The Journal of Nuclear Medicine.
Moderators: Ken Herrmann, MD (Universitätsmedizin, Essen, Germany) and Heiko Schoder, MD, MBA (Memorial Sloan Kettering Cancer Center)
Panelist: Michael J. Morris, MD (Memorial Sloan Kettering Cancer Center)
Thank you to SOFIE Biosciences for sponsoring this episode. https://sofie.com/
5 afleveringen
Delen
